Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
OBESITY IN OBSTETRICS AND GYNECOLOGY
Autore:
BONGAIN A; ISNARD V; GILLET JY;
Indirizzi:
CHU NICE SOPHIA ANTIPOLIS,HOP ARCHET 2,CTR FEMME MERE ENFANT,SERV GYNECOL OBSTET F-06202 NICE 3 FRANCE
Titolo Testata:
European journal of obstetrics, gynecology, and reproductive biology
fascicolo: 2, volume: 77, anno: 1998,
pagine: 217 - 228
SICI:
0301-2115(1998)77:2<217:OIOAG>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
BODY-FAT DISTRIBUTION; HORMONE-BINDING GLOBULIN; ENDOMETRIAL CANCER RISK; POSTMENOPAUSAL WOMEN; BREAST-CANCER; PREGNANCY COMPLICATIONS; REPRODUCTIVE FUNCTION; REPLACEMENT THERAPY; MATERNAL OBESITY; OVERWEIGHT WOMEN;
Keywords:
OBESITY; GYNECOLOGY; OBSTETRICS;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
102
Recensione:
Indirizzi per estratti:
Citazione:
A. Bongain et al., "OBESITY IN OBSTETRICS AND GYNECOLOGY", European journal of obstetrics, gynecology, and reproductive biology, 77(2), 1998, pp. 217-228

Abstract

In some countries, the incidence of obesity doubles every 10 years. For the obstetrician-gynecologist, there are many different situations where the patient's excess body weight calls for an adapted diagnosticand therapeutic approach. Obesity does not in itself appear to be a factor lowering fertility. However obesity-induced hormone disorders could contribute, in certain cases, to biological imbalance and thus favor the development of ovulation dysfunction. Pregnancy in obese women should be managed as a high risk pregnancy. The incidence of gestational diabetes and hypertension is increased. Macrosomatia is frequent. There is a 2- to 3-fold increase in the rate of cesarean sections with more complications. Fetal morbidity does not appear to be changed whenmaternal weight gain is limited. With obesity, then is an increased risk for boast and endometrial cancer due, for most authors, to elevated levels of circulating estrogens resulting from aromatization of malesex steroids in adipose tissue and decreased levels of sex hormone-binding globulin. Anesthesia and surgery in obese patients can be problematic and special care must be taken to prevent further morbidity. Laparoscopic surgery is possible under certain conditions, although its role remains to be determined. Prescription of hormone replacement musttake into consideration several parameters which determine its usefulness and surveillance. Obesity is not a contraindication for hormone replacement therapy but is frequently a non-indication. (C) 1998 Elsevier Science Ireland Ltd.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 07:18:50